Study #2018-0616
Prospective Trial of Hypofractionated Pre-Operative Radiation Therapy for Localized, Resectable Soft Tissue Sarcoma of the Extremity or Superficial Trunk (HYPORT-STS)
MD Anderson Study Status
Not Accepting
Treatment Agent
Description
This phase II trial studies the wound complication risk of shorter course, hypofractionated pre-surgery radiation therapy in treating patients with localized soft tissue sarcoma of the extremity of superficial trunk that can be removed by surgery. Hypofractionated radiation therapy delivers higher doses of radiation therapy over a shorter period of time and may kill more tumor cells and have fewer side effects. Shorter course hypofractionated pre surgery radiation therapy may be more convenient for patients with soft tissue sarcoma than a longer course of radiation therapy, and may result in fewer complications.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Resectable Soft Tissue Sarcoma;Stage I Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8;Stage IA Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8;Stage IB Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8;Stage II Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8;Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8;Stage IIIA Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8;Stage IIIB Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8
Study phase:
Phase II
Physician name:
Ashleigh Guadagnolo
Department:
Radiation Oncology
For general questions about clinical trials:
1-855-499-2252
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.